Our study group and others have demonstrated that iron chelators suppress oxidative stress by inhibiting p22phox expression and NADPH oxidase activity in diabetic obese mice [16], mice with diabetic nephropathy [23], a murine model with local inflammation [52], and in endothelial cells [53]. This evidence concerns the gene FMO5 and diabetic kidney disease.